Background Postoperative pain after cytoreductive surgery with hyperthermic intraperitoneal
chemotherapy (CRS-HIPEC) is important. It appears essential to reduce postoperative pain …

BACKGROUND: The Acute Pain Service (APS) was initially introduced to optimize
multimodal postoperative pain control. The aim of this study was to evaluate the association …

The aim of this retrospective study was to understand the impact of anesthesia management
for the patients under cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …

Purpose The aim of this study was to assess the impact of total intravenous anesthesia
(TIVA) on the perioperative inflammatory profile and clinical outcomes of patients …

Background: Studies suggest volatile anesthetics and opioids may enhance the malignant
potential of cancer cells. The objective of this single institution retrospective study was to …

Background Cytoreductive surgery combined with hyperthermic intraperitoneal
chemotherapy (CRS/HIPEC) is a treatment option for selected patients with peritoneal …

Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy
(HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed …

Background: Long-term opioid use is a well-known complication after surgery. In this
retrospective study of adults who had undergone cytoreductive surgery with hyperthermic …

Methods: Intra-operative data were collected for cases done over 1 year (24 cases) and
analysed for the primary outcome of post-operative ventilation> 24 h, and secondary …

Optimal cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) are an acceptable management modality for primary peritoneal neoplasm and …